Annals of Medicine and Surgery,
Год журнала:
2025,
Номер
87(3), С. 1487 - 1505
Опубликована: Фев. 26, 2025
Objective:
This
study
aims
to
conduct
a
bibliometric
analysis
of
the
triglyceride-glucose
(TyG)
index
in
relation
cardiovascular
disorders.
Methods:
Data
for
were
extracted
from
Web
Science
Core
Collection
database
on
13
July
2024.
We
utilized
VOSviewer,
CiteSpace,
and
Biblioshiny
tools
analysis.
Results:
The
revealed
marked
increase
research
outputs
TyG
recent
years,
peaking
with
137
publications
2023.
China
emerged
as
leading
contributor,
followed
by
USA.
Chinese
Academy
Medical
Sciences
Peking
Union
College
among
top
contributing
institutions.
Shouling
Wu
Shuohua
Chen
authors,
journal
Cardiovascular
Diabetology
publishing
most
articles
this
topic.
Keyword
identified
“insulin-resistance”
frequently
occurring
term,
“risk.”
Cluster
eleven
key
areas,
including
“percutaneous
coronary
intervention,”
“obesity
indicators,”
“arterial
stiffness,”
“heart
failure.”
Conclusion:
highlights
expanding
role
metabolic
research.
Key
clusters
such
percutaneous
intervention,
obesity
indicators,
arterial
stiffness,
heart
failure,
new-onset
hypertension,
predicting
outcomes,
subclinical
artery
disease
emphasize
its
wide
applicability
across
diverse
clinical
settings.
keyword
“risk”
was
underscoring
importance
risk
assessment,
alongside
growing
use
prognostic
applications.
These
findings
reflect
increasing
recognition
pivotal
biomarker
medicine
encourage
further
exploration
integration.
Current Issues in Molecular Biology,
Год журнала:
2024,
Номер
46(6), С. 5467 - 5487
Опубликована: Май 30, 2024
Physical
activity
is
integral
to
metabolic
health,
particularly
in
addressing
insulin
resistance
and
related
disorders
such
as
type
2
diabetes
mellitus
(T2DM).
Studies
consistently
demonstrate
a
strong
association
between
physical
levels
sensitivity.
Regular
exercise
interventions
were
shown
significantly
improve
glycemic
control,
highlighting
recommended
therapeutic
strategy
for
reducing
resistance.
inactivity
closely
linked
islet
cell
insufficiency,
exacerbating
through
various
pathways
including
ER
stress,
mitochondrial
dysfunction,
oxidative
inflammation.
Conversely,
training
preserve
restore
function,
enhancing
peripheral
Exercise
stimulate
β-cell
proliferation
increased
circulating
of
growth
factors,
further
emphasizing
its
role
maintaining
pancreatic
health
glucose
metabolism.
Furthermore,
sedentary
lifestyles
contribute
elevated
stress
ceramide
production,
impairing
signaling
induces
anti-inflammatory
responses,
enhances
antioxidant
defenses,
promotes
thereby
improving
sensitivity
efficiency.
Encouraging
individuals
adopt
active
engage
regular
crucial
preventing
managing
disorders,
ultimately
promoting
overall
well-being.
Cardiovascular Diabetology,
Год журнала:
2025,
Номер
24(1)
Опубликована: Янв. 2, 2025
Adipose
tissue
distribution
plays
a
crucial
role
in
the
development
of
cardiovascular
complications.
In
particular,
visceral
adipose
(VAT)
has
been
linked
to
insulin
resistance
(IR)
and
disease
(CVD).
However,
relationship
between
VAT,
cardiac
dysfunction
meditation
capacity
VAT
related
IR
not
fully
characterized.
This
cross-sectional
study
included
adults
living
with
type
2
diabetes
(T2D).
was
measured
using
electrical
bioimpedance
also
estimated
Metabolic
Score
for
Visceral
Fat
(METS-VF).
LV
function
assessed
left
ventricular
global
longitudinal
strain
(LV-GLS)
by
speckle
tracking
echocardiography
analysis.
Spearman
correlation
coefficients,
adjusted
linear
regression
models
guided
direct
acyclic
diagrams
causal
mediation
analysis
were
performed.
Among
195
T2D
(median
age:
57,
IQR:
49–64,
women:
63%),
showed
positive
association
LV-GLS
(β
=
0.482,
95%
CI:
0.060–0.904,
p
0.039)
after
adjusting
relevant
confounders.
The
effect
strongly
replicated
METS-VF
as
surrogate
VAT.
revealed
that
accounted
60.9%
(95%
15.82–171)
total
LV-GLS.
demonstrated
consistently
observed
clinical
METS-VF.
adiposity
identified
strong
mediator
LV-GLS,
underscoring
its
pathophysiology
patients
T2D.
Summary
main
results
study.
Abbreviations:
T2D:
Type
diabetes,
Left-ventricular
strain;
VAT:
tissue;
METS-VF,
Fat.
Medicina,
Год журнала:
2025,
Номер
61(1), С. 83 - 83
Опубликована: Янв. 7, 2025
Metabolic
syndrome
is
a
metabolic
disorder
characterized
by
hypertension,
dyslipidemia,
impaired
glucose
tolerance,
and
abdominal
obesity.
Impaired
insulin
action
or
resistance
initiates
syndrome.
The
prevalence
of
increasing
all
over
the
world.
Insulin
results
in
defective
metabolism
carbohydrates
lipids,
addition
to
low-grade
chronic
inflammation.
associated
with
syndrome,
which
risk
factor
for
number
pathological
conditions,
such
as
Type
2
diabetes
(T2D),
cardiovascular
disease
(CVD),
nonalcoholic
fatty
liver
(NAFLD),
polycystic
ovarian
(PCOS).
Genome-wide
association
studies
have
increased
our
understanding
many
loci
linked
these
diseases
others.
In
this
review,
we
discuss
its
contribution
diseases.
We
also
genetic
them.
Genetic
testing
invaluable
identification
stratification
susceptible
populations
and/or
individuals.
After
individuals
been
identified
via
screening,
lifestyle
modifications
regular
exercise,
weight
loss,
healthy
diet,
smoking
cessation
can
reduce
prevent
pathologies.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Янв. 22, 2025
Although
the
triglyceride-glucose
(TyG)
index
has
been
established
as
a
valuable
predictor
for
cardiovascular
disease
(CVD)
and
mortality,
there
is
limited
research
exploring
its
association
with
all-cause
or
CVD
mortality
specifically
in
adults
diabetes
aged
<
65
years
without
disease.
This
study
aimed
to
investigate
relationship
between
TyG
both
this
population
within
United
States.
Our
recruited
1778
from
National
Health
Nutrition
Examination
Survey
(NHANES)
2003–2018.
Mortality
outcomes
were
determined
by
linking
Death
Index
(NDI)
records
up
December
31,
2019.
Cox
regression
modeling
was
employed
examine
population.
The
nonlinear
assessed
using
restricted
cubic
splines
(RCS).
Additionally,
subgroup
analyses
interaction
tests
conducted
explore
potential
effect
modifiers.
A
total
of
1788
participants
included
final
cohort,
an
average
age
49.61
±
0.32
years.
During
median
follow-up
7.92
years,
occurrence
150
deaths
33
CVD-related
recorded.
To
independent
risks
three
models
developed.
In
Model
1,
significant
positive
observed
risk
(HR
1.38,
95%
CI
1.09–1.74).
persisted
minimally
adjusted
model
1.44,
1.13–1.83),
which
age,
gender
race.
Even
after
full
adjustment,
remained
1.91,
1.36–2.70).
We
also
found
that
linear.
Subgroup
revealed
no
interactions
stratification
variables.
However,
we
did
not
observe
results
suggested
significantly
mortality.
Cardiovascular Diabetology,
Год журнала:
2024,
Номер
23(1)
Опубликована: Июль 23, 2024
Abstract
Background
A
significant
percentage
of
patients
with
acute
coronary
syndrome
(ACS)
without
standard
modifiable
cardiovascular
risk
factors
(SMuRFs)
are
being
identified.
Nonetheless,
the
prognostic
influence
TyG
index
on
adverse
events
in
this
type
patient
remains
unexplored.
The
aim
study
was
to
assess
value
among
ACS
SMuRFs
for
predicting
outcomes.
Methods
This
involved
1140
consecutive
who
were
diagnosed
at
Beijing
Anzhen
Hospital
between
May
2018
and
December
2020
underwent
angiography.
Each
followed
up
a
period
35
66
months
after
discharge.
objective
examine
major
cardiac
cerebrovascular
(MACCE),
which
included
all-cause
mortality,
non-fatal
myocardial
infarction,
ischemic
stroke,
as
well
ischemia-driven
revascularization.
Results
During
median
follow-up
48.3
months,
220
(19.3%)
MACCE
occurred.
average
age
participants
59.55
±
10.98
years,
8.67
0.53.
In
fully
adjusted
model,
when
considering
either
continuous/categorical
variable,
associations
outcomes
observed.
Specifically,
each
1
deviation
increase
within
highest
group,
there
hazard
ratio
(HR)
1.245
(95%
confidence
interval
CI
1.030,
1.504)
1.303
1.026,
1.653)
revascularization
(both
P
<
0.05),
analyzed
continuous
variable.
Similarly,
examined
categorical
HR
CI)
group
1.693
1.051,
2.727)
(P
0.05)
while
1.855
0.998,
3.449)
=
0.051).
Additionally,
found
be
associated
poor
prognosis
subgroup.
Conclusion
is
correlated
SMuRFs,
suggesting
that
it
may
an
independent
predictive
factor
these
individuals.
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(17), С. 13622 - 13622
Опубликована: Сен. 3, 2023
Lipoprotein(a)
[Lp(a)]
is
a
well-established
risk
factor
for
cardiovascular
disease,
predisposing
to
major
events,
including
coronary
heart
stroke,
aortic
valve
calcification
and
abdominal
aneurysm.
Lp(a)
differentiated
from
other
lipoprotein
molecules
through
apolipoprotein(a),
which
possesses
atherogenic
antithrombolytic
properties
attributed
its
structure.
levels
are
mostly
genetically
predetermined
influenced
by
the
size
of
LPA
gene
variants,
with
smaller
isoforms
resulting
in
greater
synthesis
rate
apo(a)
and,
ultimately,
elevated
levels.
As
result,
serum
may
highly
vary
extremely
low
high.
Hyperlipoproteinemia(a)
defined
as
>
30
mg/dL
US
>50
Europe.
Because
association
CVD,
should
be
measured
at
least
once
lifetime
adults.
The
ultimate
goal
identify
individuals
increased
CVD
intervene
accordingly.
Traditional
pharmacological
interventions
like
niacin,
statins,
ezetimibe,
aspirin,
PCSK-9
inhibitors,
mipomersen,
estrogens
CETP
inhibitors
have
not
yet
yielded
satisfactory
results.
mean
reduction,
if
any,
barely
50%
all
agents,
statins
increasing
levels,
whereas
reduction
80–90%
appears
required
achieve
significant
decrease
events.
Novel
RNA-interfering
agents
that
specifically
target
hepatocytes
aimed
this
direction.
Pelacarsen
an
antisense
oligonucleotide,
while
olpasiran,
LY3819469
SLN360
small
interfering
RNAs,
conjugated
N-acetylgalactosamine
molecule.
Their
objective
silence
LPA,
reduce
production
lower
Evidence
thus
so
far
demonstrates
monthly
subcutaneous
administration
single
dose
yields
optimal
results
persisting
substantial
reductions
potentially
enhancing
reduction.
achieved
novel
RNA
exceed
95%.
ongoing
future
clinical
trials
eagerly
anticipated,
it
hoped
guidelines
tailored
management
these
off.
Diabetes Therapy,
Год журнала:
2024,
Номер
15(5), С. 1085 - 1098
Опубликована: Апрель 4, 2024
Early
initiation
of
intensive
insulin
therapy
has
been
demonstrated
to
be
effective
in
controlling
glycemia
and
possibly
preserving
beta-cell
function.
Innovations
formulations
delivery
systems
continue.
However,
we
have
seen
an
acceleration
the
development
new
classes
diabetes
medications
for
individuals
with
type
2
obesity,
such
as,
example,
glucagon-like
peptide-1
receptor
agonists
(GLP-1
RAs).
These
shown
confer
significant
benefits
achieving
good
glycemic
control
reduced
hypoglycemia
risk,
weight
loss,
cardiorenal
protection.
Therefore,
it
is
reasonable
question
whether
there
still
a
role
management
diabetes.
are
clear
limitations
inherent
GLP-1
RA
therapy,
including
high
rates
suboptimal
adherence
treatment
discontinuation
due
cost
side
effects,
which
diminish
long-term
efficacy,
supply
issues.
In
addition,
newer
improvements
convenience
tolerability,
even
more
when
used
conjunction
basal
insulin.
this
narrative
review,
discuss
current
evidence
that
supports
use
combination
potential
pitfalls
reliance
on
RAs
as
substitute
therapy.
Journal of Clinical Medicine,
Год журнала:
2024,
Номер
13(7), С. 2120 - 2120
Опубликована: Апрель 5, 2024
Background:
Childhood
obesity
is
a
globally
increasing
pathological
condition
leading
to
long-term
health
issues
such
as
cardiovascular
diseases
and
metabolic
syndrome
(MetS).
This
study
aimed
determine
the
clinical
value
of
Complete
Blood
Count-derived
inflammation
indexes
Monocyte/HDL-C
ratio
(MHR),
Lymphocyte/HDL-C
(LHR),
Neutrophil/HDL-C
(NHR),
System
Inflammation
Response
Index
(SIRI)
predict
presence
its
association
with
risk
markers
(HOMA-IR,
TG/HDL-C,
non-HDL-C)
in
children
adolescents
obesity.
Methods:
The
included
total
552
children/adolescents
severe
(BMI:
36.4
[32.7–40.7]
kg/m2;
219
males,
333
females;
age:
14.8
[12.9−16.3]
years),
who
were
further
subdivided
based
on
or
absence
(MetS+
MetS
respectively).
Results:
MHR,
LHR,
NHR
(p
<
0.0001),
but
not
SIRI
=
0.524),
significantly
higher
MetS+
compared
MetS−
subgroup,
showing
positive
correlation
degree
severity
0.0001).
Furthermore,
positively
associated
cardiometabolic
biomarkers
(HOMA-IR:
MHR
p
0.000,
LHR
0.001,
0.0001;
TG/HDL-C:
0.000;
non-HDL-C:
0.0001,
0.000).
Finally,
ROC
curve
analysis
demonstrated
that
among
analyzed
indexes,
only
had
diagnostic
distinguishing
patients
(MHR:
AUC
0.7045;
LHR:
0.7205;
NHR:
0.6934;
Conclusions:
In
conclusion,
index,
can
be
considered
useful
tools
for
pediatricians
assess
develop
multidisciplinary
intervention
strategies
counteract
widespread
disease.
Lipids in Health and Disease,
Год журнала:
2024,
Номер
23(1)
Опубликована: Дек. 23, 2024
The
Triglyceride-glucose
(TyG)
index
represents
a
simple,
cost-effective,
and
valid
proxy
for
insulin
resistance.
This
surrogate
marker
has
also
been
proposed
as
predictor
of
metabolic
cardiovascular
disease
(CVD).
In
this
descriptive
review,
we
aimed
to
assess
the
utility
TyG
predictive
biomarker
cardiometabolic
diseases.
A
search
was
conducted
in
PubMed,
Web
Science
identify
cross-sectional
more
importantly
prospective
studies
examining
use
biomarker.
following
terms
were
utilized
addition
index:
"insulin
resistance",
"metabolic
syndrome",
"diabetes";
"cardiovascular
diseases".
review
included
thirty
studies.
Following
adjustment
confounding
variables,
an
elevated
associated
with
significantly
increased
risk
development
Metabolic
Syndrome
(MetS),
Type
2
Diabetes,
hypertension,
CVD.
Also
limited
studies,
endothelial
dysfunction,
oxidative
stress
pro-inflammatory
phenotype.
Overall,
our
findings
support
developing
MetS,
T2DM,
well
atherosclerotic
disease.
Background
The
triglyceride-glucose
(TyG)
index
has
emerged
as
a
credible
surrogate
indicator
of
insulin
resistance
in
recent
years.
This
study
aimed
to
investigate
the
relationship
between
TyG
and
deterioration
kidney
function
patients
with
cardiovascular-kidney-metabolic
(CKM)
syndrome.